Levi & Korsinsky is investigating the Board of Directors of Gerber Scientific Inc. (“Gerber” or the “Company”) (NYSE: GRB) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vector Capital Corp. Under the terms of the transaction, Gerber shareholders will receive $11.00 per share of Gerber stock they own. Gerber shareholders also will receive a non-transferable right to receive cash payments in the future, contingent upon possible recoveries resulting from certain patent litigation claims (U.S. Patent 5,537,135). The transaction has a total approximate value of $281.8 million. Click here to learn how to join the action: http://www.zlk.com/gerber-scientific-grb.html, or call: 877-363-5972. The investigation concerns whether the Gerber Board of Directors breached their fiduciary duties to Gerber stockholders by failing to adequately shop the Company before entering into this transaction and whether Vector Capital Corp. is underpaying for Gerber shares, thus unlawfully harming Gerber stockholders. Recently, analysts have given the Company a target price as high as $11.00 per share, thus the proposed deal price offers Gerber shareholders little, if any, true premium to the market price of the Company's shares. If you own common stock in Gerber and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at 212-363-7500, toll-free: 877-363-5972, or visit http://www.zlk.com/gerber-scientific-grb.html. Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Gerber Scientific (NYSE:GRB) hit a new 52-week high Friday as it is currently trading at $11.18, above its previous 52-week high of $11.15 with 9,721 shares traded as of 10:16 a.m. ET. Average volume has been 492,800 shares over the past 30 days.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $10.87 as of 9:31 a.m. ET, 33.9% above Friday's closing price of $8.12. Volume is at 11.6 million, 217.1 times the daily average of 53,200.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $9.47 as of 9:56 a.m. ET, 20.9% above Wednesday's closing price of $7.83. Volume is at 27,319, 0.4 times the daily average of 61,900.